Aethlon Medical (NASDAQ:AEMD – Get Free Report) was upgraded by Wall Street Zen to a “sell” rating in a research report issued on Saturday. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aethlon Medical in a research report on Friday, July 17th. One equities research analyst has rated the stock with a […]